Skip to main content

Table 1 Growth/invasion inhibitory activity of compounds described in this study

From: Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum

Compound number

Compound abbreviation

Compound name

Lactone ring size

IIA IC50 (μM)

40 hour IC50 (μM)

90 hour IC50 (μM)

120 hour IC50 (μM)

1

AZRa

Azithromycin

15

10

6

7

0.04

2

AZR-desclada

-

15

50

39

31

ND

3

AZR-desglycana

-

15

>1,600

>500

285

ND

1

AZRb

Azithromycin

15

38

12

7

0.1

4

12eb,c

-

15

15

1

0.6

0.16

5

1jb,c

-

15

7

0.9

0.7

0.16

6

11cb,d

-

15

28

ND

0.9

ND

7

7/47b,e

-

15

52

ND

5

ND

8

7/25b,e

-

15

73

ND

10

ND

9

ERYa

Erythromycin

14

420

230

52

ND

10

ERY-desclada

-

14

ND

288

185

ND

11

ERY-oximea

-

14

150

85

24

ND

12

ROXa

Roxithromycin

14

83

70

27

ND

13

DIRa

Dirithromycin

14

521

15

8

ND

14

Meg-ERYa,f

6-0-megosaminyl-erythromycin

14

13

ND

ND

ND

15

SPIa

Spiramycin

16

123

15

13

ND

16

CLIa

Clindamycin

NA

743

ND

ND

ND

D10-AZRr (delayed death, resistant) comparison

1

AZRa

Azithromycin

15

-

-

-

0.16g,h

1g

AZRa

Azithromycin

15

25

ND

ND

9h

  1. aVehicle was ethanol; bvehicle was dimethyl sulfoxide (DMSO); cfrom Bukvic et al. [44]; dfrom Peric et al. [42]; efrom Hutinec et al. [43]; ffrom Goodman et al. [41]. All IC50s are for the D10-PfPHG line used throughout this study, with the exception of gwhich were undertaken with the D10 azithromycin-resistant line (D10-AZRr) made as per Goodman et al. [41]. All assays were measured by flow cytometry, with the exception of hwhich were measured by hypoxanthine uptake assays. Desclad, descladinosyl; desglycan, descladinosyl and desosaminyl; NA, not applicable; ND, not done